Scarica l'app Stockscreener
2.96
5.72%
-0.07
Precedente Chiudi:
$3.03
Aprire:
$2.94
Volume 24 ore:
4,169
Relative Volume:
1.24
Capitalizzazione di mercato:
$81.70M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+2.77%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.8568
$2.9603
Intervallo di 1 settimana:
$2.68
$3.07
Portata 52W:
$2.68
$3.07
Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile
Nome
Insight Molecular Diagnostics Inc
Settore
Industria
Telefono
949-409-7600
Indirizzo
15 CUSHING, IRVINE
Confronta IMDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMDX
Insight Molecular Diagnostics Inc
|
2.8568 | 81.22M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
423.23 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.13 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
527.53 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
115.98 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
183.63 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-28 | Iniziato | Lake Street | Buy |
| 2022-05-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | Iniziato | Stephens | Overweight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-03-17 | Ripresa | Needham | Buy |
| 2021-01-07 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | Iniziato | BTIG Research | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | Reiterato | The Benchmark Company | Speculative Buy |
| 2020-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | Iniziato | Needham | Buy |
| 2019-02-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-01-29 | Aggiornamento | Janney | Neutral → Buy |
| 2018-12-19 | Ripresa | Lake Street | Buy |
Mostra tutto
Insight Molecular Diagnostics Inc Borsa (IMDX) Ultime notizie
Insight Molecular Diagnostics Insiders Placed Bullish Bets Worth US$2.82m - Yahoo Finance
U.S. In Vitro Diagnostics (IVD) Market and Competition - GlobeNewswire
U.S. In Vitro Diagnostics (IVD) Market and Competition Insights 2025-2034Next-Gen Genomic Tools and Decentralized Testing to Transform U.S. Diagnostics Landscape - yahoo.co
Clinical Laboratory Services Market Expanding with Diagnostic Testing Growth and Automation Advancements - newstrail.com
Sepsis Diagnostics Market: Global Industry Overview, Trends, Challenges, and Regional Insights - PharmiWeb.com
Proteinase K Market Grows Amid Rising Demand for Molecular Research and Diagnostics - newstrail.com
Companion Diagnostic Technologies Market Watch: Strategic Forecasts Amid Rising Economic Volatility - newstrail.com
IVD Contract Manufacturing Services Market Watch: Strategic Forecasts Amid Rising Economic Volatility - newstrail.com
Molecular Diagnostics Market Future Business Opportunities 2025-2032 | USD 27.8 billion by 2032, CAGR of 9.1% - newstrail.com
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk - TradingView
Molecular Diagnostics Market Booming as Precision Medicine, - openPR.com
Liver Cancer Diagnostics Market Analysis 2025–2035 | Trends, Technologies & Regional Insights - PharmiWeb.com
Molecular Diagnostics Reagent Market Driven by Rising Infectious Diseases and Genetic Testing - openPR.com
PCR Molecular Diagnostics Market Global Forecast 2025–2032: Sector-Wise Insights - newstrail.com
Oncocyte Relocates HQ from Irvine to Nashville - Orange County Business Journal
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics - BioSpace
Insight Molecular Diagnostics Inc.(NasdaqCM:IMDX) dropped from Russell 3000E Growth Index - MarketScreener
Revolutionizing Healthcare: Molecular Diagnostics Market Set - openPR.com
What's Driving the Future of the Molecular Cytogenetics Market? - openPR.com
Oncology Molecular Diagnostics Market in Flux: Recession Signals, Tariff Pressures & Strategic Forecasts - newstrail.com
Insight Molecular Diagnostics shares fall 4.37% intraday after high sales ratio and sector divergence. - AInvest
Insight Molecular Diagnostics shares fall 2.46% in after-hours trading due to high price-to-sales ratio and sector fund rotation. - AInvest
Why Did Insight Molecular Plunge 12.28%? - AInvest
IMDXINSIGHT MOLECULAR DIAGNOSTICS INC Latest Stock News & Market Updates - Stock Titan
OncoCyte Rebrands to Insight Molecular Diagnostics - TipRanks
Oncocyte Changes Name to Insight Molecular Diagnostics, Relocates HQ to Nashville - MarketScreener
Point-of-Care Molecular Diagnostics Market Future Business - openPR.com
Digital PCR and Real-Time PCR Market Size Worth USD 17.54 billion by 2031 at 9.1% CAGR | The Insight Partners - GlobeNewswire
In Vitro Diagnostics Market Share worth $150.13 billion, Globally by 2030Exclusive Report by The Research Insights - PR Newswire
Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 - Labroots
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software - Business Wire
Global Molecular Diagnostics Market to Expand at a CAGR of - GlobeNewswire
Point of Care Diagnostics Market Size to Reach $82.95 Bn by 2028 Globally, at 12.7% CAGR: The Insight Partners - GlobeNewswire
Molecular Diagnostic for Infectious Diseases Market Size to - GlobeNewswire
Veterinary Diagnostics Market Set to Reach USD 7.27 Billion by 2030, Driven by Zoonotic Diseases and Technological AdvancementsThe Insight Partners - Yahoo Finance
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session - Business Wire
[Latest] Global Medical Imaging Reagents Market Size/Share Worth USD 19.31 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire
Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - GlobeNewswire
[Latest] Global Synthetic Biology Market Size/Share Worth USD 150.93 Billion by 2034 at a 25% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire
Global Antimicrobial Susceptibility Testing Market to Reach - GlobeNewswire
Nuclear Medicine Market to hit USD 54.7 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
In-Vitro Diagnostics Packaging Market Size, Share, Report, 2034 - Global Market Insights
Untargeted metabolomics profiling of gestational diabetes mellitus: insights into early diagnosis and metabolic pathway alterations - Frontiers
Clinical Reference Laboratory Market to hit USD 78 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
Hereditary Testing Market Size, Growth Outlook 2025 – 2034 - Global Market Insights
Poultry Diagnostics Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
Lyme Disease Testing Market Size & Share Report, 2034 - Global Market Insights
Proteinase K Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire
Cancer Diagnostics Market Size, Share | Global Report [2032] - Fortune Business Insights
Influenza Diagnostics Market Growth, Insights, Opportunities and Emerging Technologies | Exactitude Consultancy - GlobeNewswire
Visualization of argininosuccinate synthetase by in silico analysis: novel insights into citrullinemia type I disorders - Frontiers
Insight Molecular Diagnostics Inc Azioni (IMDX) Dati Finanziari
Non sono disponibili dati finanziari per Insight Molecular Diagnostics Inc (IMDX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
2.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):